ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,889,839 | +96.0% | 258,483 | +15.7% | 0.00% | – |
Q1 2024 | $1,474,480 | +79.8% | 223,406 | +23.2% | 0.00% | – |
Q4 2023 | $819,843 | +29.7% | 181,381 | +2.8% | 0.00% | – |
Q3 2023 | $631,888 | +5.9% | 176,505 | +9.2% | 0.00% | – |
Q2 2023 | $596,463 | +133.8% | 161,643 | +109.7% | 0.00% | – |
Q1 2023 | $255,128 | -5.0% | 77,078 | +11.4% | 0.00% | – |
Q4 2022 | $268,476 | +471.2% | 69,195 | +255.3% | 0.00% | – |
Q3 2022 | $47,000 | -11.3% | 19,473 | -27.3% | 0.00% | – |
Q2 2022 | $53,000 | +341.7% | 26,790 | +279.3% | 0.00% | – |
Q1 2021 | $12,000 | -14.3% | 7,063 | 0.0% | 0.00% | – |
Q4 2020 | $14,000 | -17.6% | 7,063 | 0.0% | 0.00% | – |
Q3 2020 | $17,000 | -45.2% | 7,063 | -32.5% | 0.00% | – |
Q2 2020 | $31,000 | +3.3% | 10,460 | 0.0% | 0.00% | – |
Q1 2020 | $30,000 | -26.8% | 10,460 | +3.3% | 0.00% | – |
Q4 2019 | $41,000 | +10.8% | 10,125 | +20.9% | 0.00% | – |
Q3 2019 | $37,000 | +94.7% | 8,377 | +67.0% | 0.00% | – |
Q2 2019 | $19,000 | +72.7% | 5,015 | +78.4% | 0.00% | – |
Q1 2019 | $11,000 | +57.1% | 2,811 | 0.0% | 0.00% | – |
Q4 2018 | $7,000 | -58.8% | 2,811 | 0.0% | 0.00% | – |
Q3 2018 | $17,000 | +30.8% | 2,811 | 0.0% | 0.00% | – |
Q2 2018 | $13,000 | – | 2,811 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |